Download PDF
Thromb Haemost 2008; 99(05): 974-976
DOI: 10.1160/TH07-10-0625
Letters to the Editor
Schattauer GmbH

Incidence and features of heparin-induced thrombocytopenia (HIT) in burn patients: A retrospective study

Carine Garcia Hejl
1   Service de Biologie and Centre de Traitement des Brûlés, Hôpital Percy, Clamart, France
,
Thomas Leclerc
2   Centre de Traitement des Brûlés, Hôpital Percy, Clamart, France
,
Laurent Bargues
2   Centre de Traitement des Brûlés, Hôpital Percy, Clamart, France
,
Thierry Samson
1   Service de Biologie and Centre de Traitement des Brûlés, Hôpital Percy, Clamart, France
,
Vincent Foissaud
1   Service de Biologie and Centre de Traitement des Brûlés, Hôpital Percy, Clamart, France
› Author Affiliations
Further Information

Publication History

Received 19 October 2007

Accepted after major revision 23 March 2008

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytopenia. Chest 2005; 127: 35S-45S.
    CrossrefPubMedGoogle Scholar
  • 2 Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 311S-337S.
    CrossrefPubMedGoogle Scholar
  • 3 Spinler SA. New concepts in Heparin-induced thrombocytopenia: diagnosis and management. J Thromb Thrombolysis 2006; 21: 17-21.
    CrossrefPubMedGoogle Scholar
  • 4 Société française d’anesthésie reanimation. Conférence d’experts. Thrombopénie induite par l’héparine. Ann Fr Anesth Reanim 2003; 22: 150-159.
    PubMedGoogle Scholar
  • 5 Lobo B, Finch C, Howard A, Minhas S. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost 2008; 99: 208-214.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Warkentin TE. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)–bridging the River Coumarin. Thromb Haemost 2008; 99: 2-3.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Gueugniaud PY, Carsin H, Bertin-Maghit M. et al. Current advances in the initial management of major thermal burns. Intensive Care Med 2000; 26: 848-856.
    CrossrefPubMedGoogle Scholar
  • 8 Société Française d’Anesthésie et de Réanimation – Agence Nationale d’Accréditation et d’Evaluation en Santé. Recommandations pour la pratique clinique (RPC). Prévention de la maladie thromboembolique veineuse péri-opératoire et obstétricale (Groupe Brûlés et chirurgie plastique). Ann Fr Anesth Reanim 2005; 24: 853-861.
    CrossrefPubMedGoogle Scholar
  • 9 Horner BM, Myers SR. Don’t miss HIT (heparin induced thrombocytopenia). Burns 2004; 30: 88-90.
    CrossrefPubMedGoogle Scholar
  • 10 Bargues L, Foissaud V, Jault P. et al. Heparin-induced thrombocytopenia: report of four cases in severely burned patients. Ann Fr Anesth Reanim 2006; 25: 1135-1139.
    CrossrefPubMedGoogle Scholar
  • 11 Scott JR, Klein MB, Gernsheimer T. et al. Arterial and venous complications of heparin-induced thrombocytopenia in burn patients. J Burn Care Res 2007; 28: 71-75.
    CrossrefPubMedGoogle Scholar
  • 12 Everett BM, Yeh R, Foo SY. et al. Prevalence of heparin/ platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg 2007; 83: 592-597.
    CrossrefPubMedGoogle Scholar
  • 13 Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Haemost 2006; 32: 803-809.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Davidson SJ, Wadham P, Rogers L. et al. Endothelial cell damage in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 2007; 18: 317-320.
    CrossrefPubMedGoogle Scholar